Rankings
▼
Calendar
TMDX FY 2023 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
FY 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$242M
+158.5% YoY
Gross Profit
$154M
63.8% margin
Operating Income
-$29M
-11.9% margin
Net Income
-$25M
-10.4% margin
EPS (Diluted)
$-0.77
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$192M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$706M
Total Liabilities
$569M
Stockholders' Equity
$137M
Cash & Equivalents
$395M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$242M
$93M
+158.5%
Gross Profit
$154M
$65M
+136.1%
Operating Income
-$29M
-$31M
+8.6%
Net Income
-$25M
-$36M
+30.9%
← Q4 2022
All Quarters
Q1 2023 →